NCT05047835

Brief Summary

Prolonged prone position ventilation reduces the 30-day mortality in acute respiratory distress syndrome (ARDS) and in COVID-19 infection. A large number of patients with COVID-19 suffered from new-onset cardiac disease, therefore, ECG is crucial. However, there is limited data on the effects of prone position on the ECG in COVID-19 patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 17, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

1.6 years

First QC Date

September 16, 2021

Last Update Submit

October 9, 2023

Conditions

Keywords

COVID-19electrocardiogramARDSProne position

Outcome Measures

Primary Outcomes (3)

  • The change of P wave amplitude

    The relative changes in P-wave amplitudes with different body positions were evaluated by dividing the 12-lead ECG into subregions (I, aVL: lateral limb leads; II, III, and aVF: inferior leads; V1 to V3: anterior precordial leads; V4 to V6: lateral precordial leads).

    The first day of admission

  • The change of QRS-complex amplitude

    The relative changes in QRS-complex amplitudes with different body positions were evaluated by dividing the 12-lead ECG into subregions (I, aVL: lateral limb leads; II, III, and aVF: inferior leads; V1 to V3: anterior precordial leads; V4 to V6: lateral precordial leads).

    The first day of admission

  • The change of T wave amplitude

    The relative changes in T wave amplitudes with different body positions were evaluated by dividing the 12-lead ECG into subregions (I, aVL: lateral limb leads; II, III, and aVF: inferior leads; V1 to V3: anterior precordial leads; V4 to V6: lateral precordial leads).

    The first day of admission

Secondary Outcomes (1)

  • Diagnosis

    The first day of admission.

Interventions

electrocardiogramDIAGNOSTIC_TEST

Prone position electrocardiogram

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

COVID-19 patients proved by nasal and pharyngeal swab for PCR, who were admitted to the COVID-19 specialized ward and were diagnosed with pulmonary infiltration from a chest x-ray.

You may qualify if:

  • COVID-19 patients who were admitted to the COVID-19 specialized ward
  • Age 18 -80 years old
  • Suffered from pulmonary infiltration

You may not qualify if:

  • Intubated patients
  • Cardiac arrest patients whether at presentation or during the study period
  • ECG cannot be performed due to anatomical defects or superficial skin problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Khon Kaen Unversity

Khon Kaen, 40002, Thailand

RECRUITING

MeSH Terms

Conditions

Cardiovascular DiseasesArrhythmias, CardiacCOVID-19

Interventions

Electrocardiography

Condition Hierarchy (Ancestors)

Heart DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Central Study Contacts

Praew Kotruchin, MD, PhD.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 16, 2021

First Posted

September 17, 2021

Study Start

September 10, 2021

Primary Completion

April 30, 2023

Study Completion

December 31, 2023

Last Updated

October 10, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

For educational or research purposes, data can be provided by contacting PI or correspondent author.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
After the study finished and for 5 years later.
Access Criteria
For educational or research purposes.

Locations